Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Any familial atrial fibrillation in which the cause of the disease is a mutation in the SCN1B gene.
Features include always present findings: Paroxysmal atrial fibrillation; and common findings: Aortic valve stenosis and Left atrial enlargement.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Heart and blood vessels | 3 | Aortic valve stenosis, Left atrial enlargement, Paroxysmal atrial fibrillation |
SCN1B function has not been fully characterized.
Atrial fibrillation, familial, 13 is associated with mutations in the SCN1B gene on chromosome 19.
Genetic testing for SCN1B is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for atrial fibrillation, familial, 13 has been reported in the published literature.
Phenotype severity distribution: 1 always present feature, 2 common features.
No clinical trials have been registered for atrial fibrillation, familial, 13.
192 publications have been identified in PubMed for atrial fibrillation, familial, 13. Research spans Epidemiology / Natural History (42%), Clinical Trial Publication (26%), and Review / Meta-Analysis (17%).
Research Type | Count | % of Total |
|---|---|---|
Disease patterns and progression | 81 | 42% |
Data assembled from 5 of 12 sources · Last updated Sep 19, 2026, 12:35 AM UTC
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
Clinical study results
50 |
26% |
Research summaries | 33 | 17% |
Testing and diagnosis research | 11 | 6% |
Laboratory research | 8 | 4% |
Other research | 7 | 4% |
New treatment approaches | 2 | 1% |
Adelman AE (2026). [PMID: 41793285](https://pubmed.ncbi.nlm.nih.gov/41793285/). *Otolaryngol Head Neck Surg*. [Gene Therapy / Novel Therapeutics]
Zhang B (2026). [PMID: 41637736](https://pubmed.ncbi.nlm.nih.gov/41637736/). *Biomol Biomed*. [Review / Meta-Analysis]
Bola H (2026). [PMID: 41922901](https://pubmed.ncbi.nlm.nih.gov/41922901/). *Europace*. [Review / Meta-Analysis]
Chen J (2026). [PMID: 41559665](https://pubmed.ncbi.nlm.nih.gov/41559665/). *BMC Med*. [Epidemiology / Natural History]
Shi T (2026). [PMID: 41864905](https://pubmed.ncbi.nlm.nih.gov/41864905/). *Cardiovasc Diabetol*. [Epidemiology / Natural History]
Wang N (2026). [PMID: 39742967](https://pubmed.ncbi.nlm.nih.gov/39742967/). *Hellenic J Cardiol*. [Epidemiology / Natural History]
Zhang W (2026). [PMID: 42077455](https://pubmed.ncbi.nlm.nih.gov/42077455/). *Front Endocrinol (Lausanne)*. [Epidemiology / Natural History]
Pannunzio A (2026). [PMID: 41835470](https://pubmed.ncbi.nlm.nih.gov/41835470/). *Front Cardiovasc Med*. [Review / Meta-Analysis]
Asplund O (2026). [PMID: 41248671](https://pubmed.ncbi.nlm.nih.gov/41248671/). *Lancet Diabetes Endocrinol*. [Epidemiology / Natural History]
Lu Y (2026). [PMID: 40921279](https://pubmed.ncbi.nlm.nih.gov/40921279/). *Int J Cardiol*. [Epidemiology / Natural History]